Search

Search Constraints

You searched for: Author/Creator Harutani, Yuhei

Search Results

1. CD24, not CD47, negatively impacts upon response to PD‐1/L1 inhibitors in non–small‐cell lung cancer with PD‐L1 tumor proportion score < 50. Issue 1 (27th November 2020)

2. Histologic transformation of epidermal growth factor receptor–mutated lung cancer. (May 2022)

3. Immune‐Related Adverse Events by Immune Checkpoint Inhibitors Significantly Predict Durable Efficacy Even in Responders with Advanced Non‐Small Cell Lung Cancer. (19th November 2019)

4. Prospective, multicentre, single-arm phase II trial of pembrolizumab combined with carboplatin and pemetrexed in elderly patients with advanced, non-squamous non-small cell lung cancer. Issue 7 (21st July 2020)